{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:51:35Z","timestamp":1792083095996,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-03937-3","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:12:14Z","timestamp":1755691934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of quality of life in patients with endometriosis undergoing treatment with progestins, oral contraceptives pills (OCP), and GnRH agonists"],"prefix":"10.1186","volume":"25","author":[{"given":"Mania","family":"Kaveh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahla","family":"Chaichian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl Mehdizadeh","family":"Kashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mohsenikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Afrouzeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambiz","family":"Sadegi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"7","key":"3937_CR1","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/biomedicines12071476","volume":"12","author":"G Cano-Herrera","year":"2024","unstructured":"Cano-Herrera G, Salmun Nehmad S, Ruiz de Ch\u00e1vez Gasc\u00f3n J, M\u00e9ndez Vionet A, van Tienhoven XA, Osorio Mart\u00ednez MF, et al. Endometriosis: A comprehensive analysis of the pathophysiology, treatment, and nutritional aspects, and its repercussions on the quality of life of patients. Biomedicines. 2024;12(7):1476.","journal-title":"Biomedicines"},{"key":"3937_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s13669-017-0187-1","volume":"6","author":"P Parasar","year":"2017","unstructured":"Parasar P, Ozcan P, Terry KL. Endometriosis: epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep. 2017;6:34\u201341.","journal-title":"Curr Obstet Gynecol Rep"},{"key":"3937_CR3","volume":"251","author":"E Pa\u0161ali\u0107","year":"2023","unstructured":"Pa\u0161ali\u0107 E, Tambuwala MM, Hromi\u0107-Jahjefendi\u0107 A. Endometriosis: classification, pathophysiology, and treatment options. Pathology. 2023;251: 154847.","journal-title":"Pathology"},{"issue":"10","key":"3937_CR4","doi-asserted-by":"publisher","first-page":"E363","DOI":"10.1503\/cmaj.220637","volume":"195","author":"C Allaire","year":"2023","unstructured":"Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ. 2023;195(10):E363-71.","journal-title":"CMAJ"},{"issue":"11","key":"3937_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41574-019-0245-z","volume":"15","author":"C Chapron","year":"2019","unstructured":"Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Reviews Endocrinol. 2019;15(11):666\u201382.","journal-title":"Nat Reviews Endocrinol"},{"key":"3937_CR6","doi-asserted-by":"crossref","unstructured":"Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379.","DOI":"10.1136\/bmj-2022-070750"},{"issue":"5","key":"3937_CR7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/jcm10051085","volume":"10","author":"J Donnez","year":"2021","unstructured":"Donnez J, Dolmans M-M. Endometriosis and medical therapy: from progestogens to progesterone resistance to GnRH antagonists: a review. J Clin Med. 2021;10(5):1085.","journal-title":"J Clin Med"},{"key":"3937_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejogrb.2021.10.029","volume":"267","author":"L El Taha","year":"2021","unstructured":"El Taha L, Musa AA, Khalifeh D, Khalil A, Abbasi S, Nassif J. Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: randomized clinical trial. Eur J Obstet Gynecol Reproductive Biology. 2021;267:205\u201312.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"key":"3937_CR9","doi-asserted-by":"crossref","unstructured":"New EP, Mikhail E. A narrative review of using GnRH analogues to reduce endometriosis recurrence after surgery: a double-edged sword. Gynecol Pelvic Med. 2021;4.","DOI":"10.21037\/gpm-2020-mtet-03"},{"issue":"3","key":"3937_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/GRF.0000000000000292","volume":"60","author":"S Rafique","year":"2017","unstructured":"Rafique S, Decherney AH. Medical management of endometriosis. Clin Obstet Gynecol. 2017;60(3):485\u201396.","journal-title":"Clin Obstet Gynecol"},{"key":"3937_CR11","doi-asserted-by":"crossref","unstructured":"Resta C, Moustogiannis A, Chatzinikita E, Ntalianis DM, Ntalianis KM, Philippou A et al. Gonadotropin-releasing hormone (GnRH)\/GnRH receptors and their role in the treatment of endometriosis. Cureus. 2023;15(4).","DOI":"10.7759\/cureus.38136"},{"key":"3937_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejogrb.2015.06.006","volume":"191","author":"F Taniguchi","year":"2015","unstructured":"Taniguchi F, Enatsu A, Ota I, Toda T, Arata K, Harada T. Effects of low dose oral contraceptive pill containing drospirenone\/ethinylestradiol in patients with endometrioma. Eur J Obstet Gynecol Reproductive Biology. 2015;191:116\u201320.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"key":"3937_CR13","doi-asserted-by":"publisher","first-page":"729601","DOI":"10.3389\/fgwh.2021.729601","volume":"2","author":"G Barbara","year":"2021","unstructured":"Barbara G, Buggio L, Facchin F, Vercellini P. Medical treatment for endometriosis: tolerability, quality of life and adherence. Front Global Women\u2019s Health. 2021;2:729601.","journal-title":"Front Global Women\u2019s Health"},{"issue":"6","key":"3937_CR14","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jadohealth.2018.06.027","volume":"63","author":"JS Gallagher","year":"2018","unstructured":"Gallagher JS, DiVasta AD, Vitonis AF, Sarda V, Laufer MR, Missmer SA. The impact of endometriosis on quality of life in adolescents. J Adolesc Health. 2018;63(6):766\u201372.","journal-title":"J Adolesc Health"},{"issue":"3","key":"3937_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/humrep\/deaa330","volume":"36","author":"R O\u2019Hara","year":"2021","unstructured":"O\u2019Hara R, Rowe H, Fisher J. Self-management factors associated with quality of life among women with endometriosis: a cross-sectional Australian survey. Hum Reprod. 2021;36(3):647\u201355.","journal-title":"Hum Reprod"},{"issue":"10","key":"3937_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17103641","volume":"17","author":"D Warzecha","year":"2020","unstructured":"Warzecha D, Szymusik I, Wielgos M, Pietrzak B. The impact of endometriosis on the quality of life and the incidence of depression\u2014a cohort study. Int J Environ Res Public Health. 2020;17(10): 3641.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"3937_CR17","doi-asserted-by":"publisher","first-page":"e0208464","DOI":"10.1371\/journal.pone.0208464","volume":"14","author":"N Bourdel","year":"2019","unstructured":"Bourdel N, Chauvet P, Billone V, Douridas G, Fauconnier A, Gerbaud L, et al. Systematic review of quality of life measures in patients with endometriosis. PLoS One. 2019;14(1):e0208464.","journal-title":"PLoS One"},{"key":"3937_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bpobgyn.2018.01.015","volume":"51","author":"P Vercellini","year":"2018","unstructured":"Vercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018;51:68\u201391.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"3937_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/03007995.2022.2031144","volume":"38","author":"K Ambacher","year":"2022","unstructured":"Ambacher K, Secter M, Sanders AP. The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review. Curr Med Res Opin. 2022;38(3):479\u201386.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"3937_CR20","first-page":"196","volume":"29","author":"M Canday","year":"2023","unstructured":"Canday M, Salman S. Impact of dienogest alone or in combination with ethinylestradiol on the quality of life of women with endometriosis: a prospective cohort study. Gynecol Obstet Reprod Med. 2023;29(3):196\u2013205.","journal-title":"Gynecol Obstet Reprod Med"},{"issue":"2","key":"3937_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpag.2016.02.008","volume":"30","author":"JS Gallagher","year":"2017","unstructured":"Gallagher JS, Feldman HA, Stokes NA, Laufer MR, Hornstein MD, Gordon CM, et al. The effects of gonadotropin-releasing hormone agonist combined with add-back therapy on quality of life for adolescents with endometriosis: a randomized controlled trial. J Pediatr Adolesc Gynecol. 2017;30(2):215\u201322.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"12","key":"3937_CR22","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/humrep\/dead214","volume":"38","author":"A Van Haaps","year":"2023","unstructured":"Van Haaps A, Wijbers J, Schreurs A, Vlek S, Tuynman J, De Bie B, et al. The effect of dietary interventions on pain and quality of life in women diagnosed with endometriosis: a prospective study with control group. Hum Reprod. 2023;38(12):2433\u201346.","journal-title":"Hum Reprod"},{"key":"3937_CR23","doi-asserted-by":"publisher","first-page":"1230303","DOI":"10.3389\/fpubh.2023.1230303","volume":"11","author":"M Szyp\u0142owska","year":"2023","unstructured":"Szyp\u0142owska M, Tarkowski R, Ku\u0142ak K. The impact of endometriosis on depressive and anxiety symptoms and quality of life: a systematic review. Front Public Health. 2023;11:1230303.","journal-title":"Front Public Health"},{"issue":"2","key":"3937_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.rbmo.2020.04.014","volume":"41","author":"E Huijs","year":"2020","unstructured":"Huijs E, Nap A. The effects of nutrients on symptoms in women with endometriosis: a systematic review. Reprod Biomed Online. 2020;41(2):317\u201328.","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"3937_CR25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.rbmo.2021.07.011","volume":"43","author":"I Krabbenborg","year":"2021","unstructured":"Krabbenborg I, de Roos N, van der Grinten P, Nap A. Diet quality and perceived effects of dietary changes in Dutch endometriosis patients: an observational study. Reprod Biomed Online. 2021;43(5):952\u201361.","journal-title":"Reprod Biomed Online"},{"issue":"21","key":"3937_CR26","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.3390\/diagnostics14212344","volume":"14","author":"FG Martire","year":"2024","unstructured":"Martire FG, d\u2019Abate C, Schettini G, Cimino G, Ginetti A, Colombi I, et al. Adenomyosis and adolescence: A challenging diagnosis and complex management. Diagnostics. 2024;14(21):2344.","journal-title":"Diagnostics"},{"issue":"10","key":"3937_CR27","doi-asserted-by":"publisher","first-page":"e0223316","DOI":"10.1371\/journal.pone.0223316","volume":"14","author":"M Armour","year":"2019","unstructured":"Armour M, Lawson K, Wood A, Smith CA, Abbott J. The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: a national online survey. PLoS One. 2019;14(10):e0223316.","journal-title":"PLoS One"},{"issue":"5","key":"3937_CR28","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/humrep\/des073","volume":"27","author":"S Simoens","year":"2012","unstructured":"Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012;27(5):1292\u20139.","journal-title":"Hum Reprod"},{"issue":"1","key":"3937_CR29","first-page":"6653677","volume":"2021","author":"A Pantelis","year":"2021","unstructured":"Pantelis A, Machairiotis N, Lapatsanis DP. The formidable yet unresolved interplay between endometriosis and obesity. Sci World J. 2021;2021(1):6653677.","journal-title":"Sci World J"},{"issue":"5","key":"3937_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.molmed.2023.02.004","volume":"29","author":"WM Pardridge","year":"2023","unstructured":"Pardridge WM. Brain gene therapy with trojan horse lipid nanoparticles. Trends Mol Med. 2023;29(5):343\u201353.","journal-title":"Trends Mol Med"},{"issue":"1","key":"3937_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1056\/NEJMoa1700089","volume":"377","author":"HS Taylor","year":"2017","unstructured":"Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377(1):28\u201340.","journal-title":"N Engl J Med"},{"issue":"11","key":"3937_CR32","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1177\/1933719114549848","volume":"21","author":"B Carr","year":"2014","unstructured":"Carr B, Dmowski WP, O\u2019Brien C, Jiang P, Burke J, Jimenez R, et al. Elagolix, an oral GnRH antagonist, versus subcutaneous depot Medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density. Reproductive Sci. 2014;21(11):1341\u201351.","journal-title":"Reproductive Sci"},{"key":"3937_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00404-011-1941-7","volume":"285","author":"F Petraglia","year":"2012","unstructured":"Petraglia F, Hornung D, Seitz C, Faustmann T, Gerlinger C, Luisi S, et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet. 2012;285:167\u201373.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"3937_CR34","first-page":"170","volume":"18","author":"N Karpowicz","year":"2024","unstructured":"Karpowicz N, M\u0105czka K, Skoczylas A, Pacocha N, Kunicki M, Grymowicz M, et al. The most common side effects, concerns and discontinuation patterns of oral contraceptive pills among Polish women: A Cross-Sectional study. J Family Reproductive Health. 2024;18(3):170.","journal-title":"J Family Reproductive Health"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03937-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03937-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03937-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:29:34Z","timestamp":1757410174000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03937-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3937"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03937-3","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Zabol University of Medical Sciences (Approval No. IR.ZBMU.REC.1404.010). All procedures involving human participants were conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"397"}}